πŸ‡ΊπŸ‡Έ FDA
Patent

US 10385080

STAT6 inhibitors

granted A61KA61K45/06A61K9/0043

Quick answer

US patent 10385080 (STAT6 inhibitors) held by The Board of Regents of the University of Texas System expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K45/06, A61K9/0043, A61K9/0073, A61P